American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 197-207, February 2009

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis

  • Michel Chonchol, MD

      Affiliations

    • University of Colorado Health Science Center, Denver, CO
    • Corresponding Author InformationAddress correspondence to Michel Chonchol, MD, Associate Professor, University of Colorado Health Sciences Center, Division of Renal Diseases and Hypertension, 4200 E. 9th Ave, Box C-281, Denver, CO 80262
    • ,
  • Francesco Locatelli, MD

      Affiliations

    • Azienda Ospedaliera di Lecco, Nephrology, Lecco, Italy
    • ,
  • Hanna E. Abboud, MD

      Affiliations

    • University of Texas Health Science Center, San Antonio, TX
    • ,
  • Chaim Charytan, MD

      Affiliations

    • NY Hospital Medical Center of Queens, Flushing, NY
    • ,
  • Angel L.M. de Francisco, MD

      Affiliations

    • Hospital Margues de Valdecilla, Santander, Spain
    • ,
  • Shivinder Jolly, MD

      Affiliations

    • Clinical Research Solutions, Kitchener, Ontario, Canada
    • ,
  • Mark Kaplan, MD

      Affiliations

    • Nephrology Associates, Nashville, TN
    • ,
  • Simon D. Roger, MD

      Affiliations

    • Northern Sydney Central Coast Health, Gosford, NSW, Australia
    • ,
  • Shyamal Sarkar, MD

      Affiliations

    • Advanced Kidney Specialists, Jackson, TN
    • ,
  • Moetaz B. Albizem, MD

      Affiliations

    • Amgen Inc, Thousand Oaks, CA
    • ,
  • T. Christian H. Mix, MD

      Affiliations

    • Amgen Inc, Thousand Oaks, CA
    • ,
  • Yumi Kubo, MS

      Affiliations

    • Amgen Inc, Thousand Oaks, CA
    • ,
  • Geoffrey A. Block, MD

      Affiliations

    • Denver Nephrology PC, Denver, CO

Received 13 February 2008; accepted 9 September 2008. published online 25 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 A list of author affiliations appears at the end of this article.

 Trial registration: http://clinicaltrials.gov; study number: NCT00094484.

 Originally published online as doi:10.1053/j.ajkd.2008.09.021 on December 25, 2008.

PII: S0272-6386(08)01569-2

doi:10.1053/j.ajkd.2008.09.021

Refers to article:

  • Is It Worth Correcting Hyperparathyroidism if Hyperphosphatemia and Hypocalcemia Worsen? A Cinacalcet Story

    Kamyar Kalantar-Zadeh, Csaba P. Kovesdy
    American Journal of Kidney Diseases February 2009 (Vol. 53, Issue 2, Pages 183-188)

American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 197-207, February 2009

Article Tools

* Image Usage & Resolution